Wakam commits to precision psychiatry: €250,000 to transform mental health. On 13 April 2026 in London, Wakam will present the first Precision Mind Prize, worth €250,000, in partnership with the FondaMental Foundation. This investment in Franco-British research on psychiatric biomarkers illustrates how insurance can play an active role in reducing one of the sector's most costly and least understood risks. Mental health: the underestimated risk weighing heavily on the bottom line Mental health disorders now represent one of the most dynamic claims areas for insurers: the leading cause of long-term sick leave in Europe, a growing driver of disability claims and income protection benefits, and an aggravating factor in many chronic conditions covered by supplemental health insurance. Yet unlike cancer or cardiovascular disease, psychiatry remains a field without validated biological markers. No objective tool for early diagnosis, no reliable criteria for risk stratification, no personalised treatment to reduce claims duration. For insurers, this makes it a risk that is difficult to model, and therefore difficult to manage. This is precisely the scientific barrier that Wakam has chosen to help break down. The Precision Mind Prize: a bet on transforming psychiatric risk Wakam, in partnership with the FondaMental Foundation, is launching the Precision Mind Prize: a €250,000 endowment designed to fund a collaborative Franco-British research project on psychiatric biomarkers. These biological indicators - blood based, neuroimaging, or digital - are the key to transforming psychiatry into a precision medicine discipline, much like what has already been achieved in oncology and cardiology. Supported projects aim to: * Diagnose earlier - detecting disorders before they worsen and generate lengthy, costly claims; * Personalise treatments - reducing the time to effective care, and therefore the duration of sick leave and disability; * Break the taboos around mental illness - destigmatising psychiatric conditions to improve their declaration and overall management. For the insurance sector, the implications are direct: a deeper understanding of biomarkers opens the door to finer risk modelling, better-calibrated income protection products, and more effective prevention policies. 13 April in London: the inaugural Precision Mind Prize ceremony The ceremony will take place in London on 13 April 2026. Olivier Jaillon, Chairman of the Board of the Wakam Group, will announce the winners, selected by a panel of Franco-British experts. The date and venue are no coincidence: they reflect Wakam's Franco-British roots - present across continental Europe and the United Kingdom - and its ambition to build an international scientific partnership commensurate with the challenges ahead. Wakam: the insurer investing in upstream risk prevention This initiative is part of the Wakam for Good strategy, Wakam's endowment fund, and its purpose as a mission-driven company. It reflects a strong conviction: the insurer of the future cannot settle for managing claims. It must invest in the conditions that reduce the frequency and severity of the risks it covers. "Economic and social shifts are accelerating vulnerabilities. As insurers, we believe that innovation and progress must serve people. The Precision Mind Prize will accelerate research in precision mental health and pave the way for truly personalised medicine." Catherine Charrier-Leflaive, CEO of the Wakam Group and President of Wakam for Good "Beyond enabling better and more precise patient care, this research will contribute to destigmatisation by demonstrating that many mental illnesses are, in reality, physiological conditions." Olivier Jaillon, Chairman of the Board - Wakam Group "This prize aspires to be a true catalyst for Franco-British research in precision psychiatry. It invites researchers, start-ups, and companies to join forces to transform our understanding of mental illness." Marion Leboyer, CEO of the FondaMental Foundation

Wakam UK ltd partners with Vitesse to accelerate claims payments and unlock capital growth for MGA and TPA networks. Wakam UK ltd, a leading digital insurer serving MGA's, brokers and the embedded insurance market, has partnered with Vitesse, the trusted financial infrastructure platform for the global insurance ecosystem, to transform claims fund management and improve capital efficiency for its network of managing general agents (MGAs) and third-party administrators (TPAs). As Wakam UK ltd expands across the UK and Europe, the company is adopting Vitesse's platform to deliver real-time visibility, control and integrity of claims funds and data. The move replaces manual processes with a centralized funding model, enabling real-time payments, reducing financial leakage, freeing up capital, and strengthening operational capabilities. "Partnering with Vitesse has transformed how we manage and move claims funds. We've gained real-time visibility, control, and confidence in every payment, ensuring approved claims reach the right beneficiaries quickly and securely," said Dean Witherington, Chief Claims Officer, Wakam UK ltd. "The automation, transparency and consistent claims data across partners have significantly reduced manual reconciliation and the risk of leakage across the process, saving us time and money that we can reinvest into customer service and innovation." Across the industry, loss funds frequently hold 16 - 24+ weeks of expected paid losses, tying up capital across delegated authority programs. By moving to Vitesse's centralized model, Wakam UK ltd has been able to operate with 6 - 7 weeks of reserves, freeing capital to support new product launches and accelerate expansion across Europe. "Wakam UK ltd's adoption of our infrastructure shows what's possible when insurers bring financial control and claims fund management onto a single, trusted platform," said Phil McGriskin, CEO of Vitesse. "They're achieving faster settlements, greater liquidity, and tighter control that helps minimize leakage and strengthen customer trust." The shift is also delivering tangible benefits to Wakam UK ltd's partner network. More than 50 MGA and TPA partners have been onboarded to the Vitesse platform, giving them faster access to Wakam UK ltd's claims funds and eliminating the need to use their own capital to settle claims. The platform's automation of fund flows, reconciliation, and reporting reduces administrative workloads and provides real-time insight into available funds, improving speed and accuracy in claims payments. It also standardizes the flow of claims data back to Wakam UK ltd, strengthening reporting quality and operational consistency across partners. Vitesse's platform serves as the financial infrastructure for the insurance ecosystem, enabling claims fund optimization, real-time global payments, and regulatory alignment across jurisdictions. Licensed by the FCA in the UK and the DNB in Europe, Vitesse has facilitated more than $20 billion in payments across 200+ countries and currencies.